Document is current

Any future updates will be listed below

Independent endpoint event review for the elimination of reporting bias in an open label phase III pharmaceutical trial

Crossref DOI link: https://doi.org/10.1186/1745-6215-16-S2-P188

Published Online: 2015-11-16

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark